- Nachrichtendetail
-
11.03.2024 12:15:37 - dpa-AFX: *REGENERON PHARMA: FDA APPROVES PRALUENT INJECTION TO TREAT CHILDREN WITH GENETIC FORM OF HIGH CHOLESTEROL
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Regeneron Pharmaceuticals | 881535 | NASDAQ | 985,930 | 14.05.24 21:54:30 | +8,970 | +0,92% | 984,770 | 986,040 | 980,000 | 976,960 |
